Anthem Blue Cross Blue Shield of Colorado prior authorization, page 57

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0536URed blood cell antigen (fetal RhD), PCR analysis of exon 4 of RHD gene and housekeeping control gene GAPDH from whole blood in pregnant individuals at 10+ weeks gestation knowColorado Prior Authorization List, Pg 134 Original policy
0537UOncology (colorectal cancer), analysis of cell-free DNA for epigenomic patterns, next-generation sequencing, >2500 differentially methylated regions (DMRs), plasma, algorithmColorado Prior Authorization List, Pg 135 Original policy
0538UOncology (solid tumor), next-generation targeted sequencing analysis, formalin- fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis of 600 genes, interrogation for singleColorado Prior Authorization List, Pg 135 Original policy
0539UOncology (solid tumor), cell-free circulating tumor DNA (ctDNA), 152 genes, next- generation sequencing, interrogation for single-nucleotide variants, insertions/deletions, genColorado Prior Authorization List, Pg 135 Original policy
0540UTransplantation medicine, quantification of donor-derived cell-free DNA using next-generation sequencing analysis of plasma, reported as percentage of donor- derived cell-freeColorado Prior Authorization List, Pg 135 Original policy
0543UOncology (solid tumor), next-generation sequencing of DNA from formalin-fixed paraffin-embedded (FFPE) tissue of 517 genes, interrogation for single- nucleotide variants, multiColorado Prior Authorization List, Pg 135 Original policy
0544TTranscatheter mitral valve annulus reconstruction, with implantation of adjustable annulus reconstruction device, percutaneous approach including transseptal punctureColorado Prior Authorization List, Pg 135 Original policy
0545TTranscatheter tricuspid valve annulus reconstruction with implantation of adjustable annulus reconstruction device, percutaneous approachColorado Prior Authorization List, Pg 135 Original policy
0546TRadiofrequency spectroscopy, real time, intraoperative margin assessment, at the time of partial mastectomy, with reportColorado Prior Authorization List, Pg 135 Original policy
0547UNeurofilament light chain (NfL), chemiluminescent enzyme immunoassay, plasma, quantitativeColorado Prior Authorization List, Pg 135 Original policy
0549UOncology (urothelial), DNA, quantitative methylated real-time PCR of TRNA-Cys, SIM2, and NKX1-1, using urine, diagnostic algorithm reported as a probability index for bladderColorado Prior Authorization List, Pg 135 Original policy
0552TLow-level laser therapy, dynamic photonic and dynamic thermokinetic energies, provided by a physician or other qualified health care professionalColorado Prior Authorization List, Pg 135 Original policy
0552UReproductive medicine (preimplantation genetic assessment), analysis for known genetic disorders from trophectoderm biopsy, linkage analysis of disease-causing locus, and whenColorado Prior Authorization List, Pg 135 Original policy
0553UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangColorado Prior Authorization List, Pg 135 Original policy
0554UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from trophectoderm biopsy for aneuploidy, ploidy, aColorado Prior Authorization List, Pg 135 Original policy
0555UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangColorado Prior Authorization List, Pg 135 Original policy
0560UOncology (minimal residual disease [MRD]), genomic sequence analysis, cell- free DNA, whole blood and tumor tissue, baseline assessment for design and construction of a personaColorado Prior Authorization List, Pg 135 Original policy
0561UOncology (minimal residual disease [MRD]), genomic sequence analysis, cell- free DNA, whole blood, subsequent assessment with comparison to initial assessment to evaluate for MColorado Prior Authorization List, Pg 135 Original policy
0562UOncology (solid tumor), targeted genomic sequence analysis, 33 genes, detection of single-nucleotide variants (SNVs), insertions and deletions, copy- number amplifications, andColorado Prior Authorization List, Pg 135 Original policy
0563TEvacuation of meibomian glands, using heat delivered through wearable, open- eye eyelid treatment devices and manual gland expression, bilateralColorado Prior Authorization List, Pg 135 Original policy
0565TAutologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; tissue harvesting and cellular implant creationColorado Prior Authorization List, Pg 135 Original policy
0565UOncology (hepatocellular carcinoma), next-generation sequencing methylation pattern assay to detect 6626 epigenetic alterations, cell-free DNA, plasma, algorithm reported as cColorado Prior Authorization List, Pg 135 Original policy
0566TAutologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; injection of cellular implant into knee joint including ultrasound guColorado Prior Authorization List, Pg 136 Original policy
0566UOncology (lung), qPCR-based analysis of 13 differentially methylated regions (CCDC181, HOXA7, LRRC8A, MARCHF11, MIR129-2, NCOR2, PANTR1, PRKCB, SLC9A3, TBR1_2, TRAP1, VWC2, ZNColorado Prior Authorization List, Pg 136 Original policy
0567URare diseases (constitutional/heritable disorders), whole-genome sequence analysis combination of short and long reads, for single-nucleotide variants, insertions/deletions anColorado Prior Authorization List, Pg 136 Original policy
0568UNeurology (dementia), beta amyloid (AB40, AB42, AB42/40 ratio), tau-protein phosphorylated at residue (eg, pTau217), neurofilament light chain (NfL), and glial fibrillary acidColorado Prior Authorization List, Pg 136 Original policy
0569TTranscatheter tricuspid valve repair, percutaneous approach; initial prosthesisColorado Prior Authorization List, Pg 136 Original policy
0569UOncology (solid tumor), next-generation sequencing analysis of tumor methylation markers (>20000 differentially methylated regions) present in cell- free circulating tumor DNAColorado Prior Authorization List, Pg 136 Original policy
0571UOncology (solid tumor), DNA (80 genes) and RNA (10 genes), by next-generation sequencing, plasma, including single-nucleotide variants, insertions/deletions, copy-number alterColorado Prior Authorization List, Pg 136 Original policy
0580TRemoval of substernal implantable defibrillator pulse generator onlyColorado Prior Authorization List, Pg 136 Original policy
0581TAblation, malignant breast tumor(s), percutaneous, cryotherapy, including imaging guidance when performed, unilateralColorado Prior Authorization List, Pg 136 Original policy
0584TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when perfColorado Prior Authorization List, Pg 136 Original policy
0585TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when perfColorado Prior Authorization List, Pg 136 Original policy
0586TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when perfColorado Prior Authorization List, Pg 136 Original policy
0587TPercutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generatorColorado Prior Authorization List, Pg 136 Original policy
0588TRevision or removal of percutaneously placed integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generatorColorado Prior Authorization List, Pg 136 Original policy
0589UPerfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 24 PFAS compounds by high-performance liquid chromatography with tandem mass specColorado Prior Authorization List, Pg 136 Original policy
0596TTemporary female intraurethral valve-pump (ie, voiding prosthesis); initial insertion, including urethral measurementColorado Prior Authorization List, Pg 136 Original policy
0597TTemporary female intraurethral valve-pump (ie, voiding prosthesis); replacementColorado Prior Authorization List, Pg 136 Original policy
0600TAblation, irreversible electroporation; 1 or more tumors per organ, other than liver or prostate, including imaging guidance, when performed, percutaneousColorado Prior Authorization List, Pg 136 Original policy
0601TAblation, irreversible electroporation; 1 or more tumors per organ, including fluoroscopic and ultrasound guidance, when performed, openColorado Prior Authorization List, Pg 136 Original policy
0607TRemote monitoring of an external continuous pulmonary fluid monitoring system, including measurement of radiofrequency-derived pulmonary fluid levels, heart rate, respirationColorado Prior Authorization List, Pg 136 Original policy
0608TRemote monitoring of an external continuous pulmonary fluid monitoring system, including measurement of radiofrequency-derived pulmonary fluid levels, heart rate, respirationColorado Prior Authorization List, Pg 136 Original policy
0615TAutomated analysis of binocular eye movements without spatial calibration, including disconjugacy, saccades, and pupillary dynamics for the assessment of concussion, with inteColorado Prior Authorization List, Pg 136 Original policy
0620TEndovascular venous arterialization, tibial or peroneal vein, with transcatheter placement of intravascular stent graft(s) and closure by any method, including percutaneous orColorado Prior Authorization List, Pg 137 Original policy
0627TPercutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with fluoroscopic guidance, lumbar; first leColorado Prior Authorization List, Pg 137 Original policy
0629TPercutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with CT guidance, lumbar; first levelColorado Prior Authorization List, Pg 137 Original policy
0633TComputed tomography, breast, including 3D rendering, when performed, unilateral; without contrast materialColorado Prior Authorization List, Pg 137 Original policy
0634TComputed tomography, breast, including 3D rendering, when performed, unilateral; with contrast material(s)Colorado Prior Authorization List, Pg 137 Original policy
0635TComputed tomography, breast, including 3D rendering, when performed, unilateral; without contrast, followed by contrast material(s)Colorado Prior Authorization List, Pg 137 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.